Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Remdesivir  COVID-19 treatment studies for Remdesivir  C19 studies: Remdesivir  Remdesivir   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   All Outcomes   Recent:  
Assessing Efficacy of Antiviral Therapy for COVID-19 Patients: A Case Study on Remdesivir with Bayesian Synthesis Design and Multistate Analysis
Liao et al., Journal of the Formosan Medical Association, doi:10.1016/j.jfma.2021.04.026 (meta analysis)
Liao et al., Assessing Efficacy of Antiviral Therapy for COVID-19 Patients: A Case Study on Remdesivir with Bayesian.., Journal of the Formosan Medical Association, doi:10.1016/j.jfma.2021.04.026 (meta analysis)
May 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Bayesian synthesis design and multistate analysis of remdesivir results showing 31% [18-44%] lower risk of death and 10% [1-18%] higher recovery.
Currently there are 48 remdesivir studies and meta analysis shows:
OutcomeImprovement
Mortality14% lower [5‑21%]
Ventilation10% higher [-22‑54%]
ICU admission33% higher [10‑62%]
Hospitalization3% higher [-20‑32%]
Liao et al., 4 May 2021, peer-reviewed, 7 authors.
All Studies   All Outcomes   Submit Updates or Corrections
This PaperRemdesivirAll
Abstract: Journal of the Formosan Medical Association 120 (2021) S77eS85 Available online at www.sciencedirect.com ScienceDirect journal homepage: www.jfma-online.com Original Article Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis Sih-Han Liao a,b,c, Chien-Ching Hung d,e, Chiung-Nien Chen f,g, Jui-Yi Yen h, Chen-Yang Hsu a,i, Amy Ming-Fang Yen j, Chi-Ling Chen a,g,k,* a Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan b Section of Gastroenterology, Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan c Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan d Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan e Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan f Center for Functional Image and Interventional Therapy, National Taiwan University, Taipei, Taiwan g Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan h Department of Anesthesiology, Taipei Veterans General Hospital, Taipei, Taiwan i Dachung Hospital, Miaoli, Taiwan j School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan k Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan Received 6 April 2021; received in revised form 18 April 2021; accepted 21 April 2021 KEYWORDS Antiviral therapy; COVID-19; Remdesivir; Clinical efficacy; Background/purpose: A synthesis design and multistate analysis is required for assessing the clinical efficacy of antiviral therapy on dynamics of multistate disease progression and in reducing the mortality and enhancing the recovery of patients with COVID-19. A case study on remdesivir was illustrated for the clinical application of such a novel design and analysis. Methods: A Bayesian synthesis design was applied to integrating the empirical evidence on the one-arm compassion study and the two-arm ACTT-1 trial for COVID-19 patients treated with * Corresponding author. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, 7 Chung-Shan South Road, Taipei, 100, Taiwan. Fax: þ886 2 23709820. E-mail address: chlnchen@ntu.edu.tw (C.-L. Chen). https://doi.org/10.1016/j.jfma.2021.04.026 0929-6646/Copyright ª 2021, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). S.-H. Liao, C.-C. Hung, C.-N. Chen et al. Bayesian synthesis sequential design remdesivir. A multistate model was developed to model the dynamics of hospitalized COVID-19 patients from three transient states of low, medium-, and high-risk until the two outcomes of recovery and death. The outcome measures for clinical efficacy comprised high-risk state, death, and discharge. Results: The efficacy of remdesivir in reducing the risk of death and enhancing the odds of recovery were estimated as 31% (95% CI, 18e44%) and 10% (95% CI, 1e18%), respectively. Remdesivir therapy for patients with low-risk state showed the efficacy in reducing subsequent progression to high-risk..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit